Hiroshi Sakagami

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 25

Top Venues

Medicines (Basel, Switzerland)

International journal of molecular sciences

Molecules (Basel, Switzerland)

Turkish journal of chemistry

Meikai University School of Dentistry

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Meikai University School of Dentistry Apr 01 2017

Japan

Professor :: Meikai University Research Institute of Odontology (M-RIO)

Publications

Hiroshi Sakagami
Medicines-Aims and Scope Updates. Medicines (Basel, Switzerland) 11 (5) (2024)
Swagatika Das, Praveen K Roayapalley, Hiroshi Sakagami, Naoki Umemura, Dennis K J Gorecki, Mohammad Hossain, Masami Kawase, Umashankar Das, Jonathan R Dimmock
Dimeric 3,5-Bis(benzylidene)-4-piperidones: Tumor-Selective Cytotoxicity and Structure-Activity Relationships. Medicines (Basel, Switzerland) 11 (1) (2024)
Swagatika Das, Praveen K Roayapalley, Hiroshi Sakagami, Naoki Umemura, Dennis K J Gorecki, Mohammad Hossain, Masami Kawase, Umashankar Das, Jonathan R Dimmock
Dimeric 3,5-Bis(benzylidene)-4-piperidones: Tumor-Selective Cytotoxicity and Structure-Activity Relationships. Medicines (Basel, Switzerland) 11 (1) (2024)
Hiroshi Sakagami
Medicines-Aims and Scope Updates. Medicines (Basel, Switzerland) 11 (5) (2024)
Swagatika Das, Praveen K Roayapalley, Hiroshi Sakagami, Naoki Umemura, Dennis K J Gorecki, Mohammad Hossain, Masami Kawase, Umashankar Das, Jonathan R Dimmock
Dimeric 3,5-Bis(benzylidene)-4-piperidones: Tumor-Selective Cytotoxicity and Structure-Activity Relationships. Medicines (Basel, Switzerland) 11 (1) (2024)
Ryuichiro Suzuki, Yoshiaki Shirataki, Akito Tomomura, Kenjiro Bandow, Hiroshi Sakagami, Mineko Tomomura
Isolation of Pro-Osteogenic Compounds from Euptelea polyandra That Reciprocally Regulate Osteoblast and Osteoclast Differentiation. International journal of molecular sciences 24 (24) (2023)
Tomoyuki Abe, Hiroshi Sakagami, Shigeru Amano, Shin Uota, Kenjiro Bandow, Yoshihiro Uesawa, Shiori U, Hiroki Shibata, Yuri Takemura, Yu Kimura, Koichi Takao, Yoshiaki Sugita, Akira Sato, Sei-Ichi Tanuma, Hiroshi Takeshima
A Comparative Study of Tumor-Specificity and Neurotoxicity between 3-Styrylchromones and Anti-Cancer Drugs. Medicines (Basel, Switzerland) 10 (7) (2023)
Ryuichiro Suzuki, Yoshiaki Shirataki, Akito Tomomura, Kenjiro Bandow, Hiroshi Sakagami, Mineko Tomomura
Isolation of Pro-Osteogenic Compounds from Euptelea polyandra That Reciprocally Regulate Osteoblast and Osteoclast Differentiation. International journal of molecular sciences 24 (24) (2023)
Ignacio Jimenez-Bueno, René García-Contreras, Benjamin Aranda-Herrera, Hiroshi Sakagami, Christian Andrea Lopez-Ayuso, Hiroshi Nakajima, Carlos Alberto Jurado, Hamid Nurrohman
Cytotoxicity, Differentiation, and Biocompatibility of Root-End Filling: A Comprehensive Study. Biomimetics (Basel, Switzerland) 8 (7) (2023)
Mohammed Abdelmalek Orabi, Esam A Orabi, Ahmed Abdullah Al Awadh, Mohammed Merae Alshahrani, Basel A Abdel Wahab, Hiroshi Sakagami, Tsutomu Hatano
New Megastigmane and Polyphenolic Components of Henna Leaves and Their Tumor-Specific Cytotoxicity on Human Oral Squamous Carcinoma Cell Lines. Antioxidants (Basel, Switzerland) 12 (11) (2023)
Sei-Ichi Tanuma, Takahiro Oyama, Miwa Okazawa, Hiroaki Yamazaki, Koichi Takao, Yoshiaki Sugita, Shigeru Amano, Takehiko Abe, Hiroshi Sakagami
A Dual Anti-Inflammatory and Anti-Proliferative 3-Styrylchromone Derivative Synergistically Enhances the Anti-Cancer Effects of DNA-Damaging Agents on Colon Cancer Cells by Targeting HMGB1-RAGE-ERK1/2 Signaling. International journal of molecular sciences 23 (7) (2022)
Mohammad Hossain, Praveen K Roayapalley, Hiroshi Sakagami, Keitaro Satoh, Kenjiro Bandow, Umashankar Das, Jonathan R Dimmock
Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells. Medicines (Basel, Switzerland) 9 (6) (2022)
Kotone Naitoh, Yuta Orihara, Hiroshi Sakagami, Takumi Miura, Keitaro Satoh, Shigeru Amano, Kenjiro Bandow, Yosuke Iijima, Kota Kurosaki, Yoshihiro Uesawa, Masashi Hashimoto, Hidetsugu Wakabayashi
Tumor-Specificity, Neurotoxicity, and Possible Involvement of the Nuclear Receptor Response Pathway of 4,6,8-Trimethyl Azulene Amide Derivatives. International journal of molecular sciences 23 (5) (2022)
Aruna Chhikara, Praveen K Roayapalley, Hiroshi Sakagami, Shigeru Amano, Keitaro Satoh, Yoshihiro Uesawa, Umashankar Das, Swagatika Das, Edgar A Borrego, Cristina D Guerena, Clare R Hernandez, Renato J Aguilera, Jonathan R Dimmock
Novel Unsymmetric 3,5-Bis(benzylidene)-4-piperidones That Display Tumor-Selective Toxicity. Molecules (Basel, Switzerland) 27 (19) (2022)
Hiroshi Sakagami, Sachie Nakatani, Ayame Enomoto, Sana Ota, Miku Kaneko, Masahiro Sugimoto, Misaki Horiuchi, Kazuki Toeda, Takaaki Oizumi
Multi-Omics Analysis of Anti-Inflammatory Action of Alkaline Extract of the Leaves of Sasa sp. Journal of clinical medicine 10 (10) (2021)
Praveen K Roayapalley, Jonathan R Dimmock, Lisett Contreras, Karol S Balderrama, Renato J Aguilera, Hiroshi Sakagami, Shigeru Amano, Rajendra K Sharma, Umashankar Das
Design, Synthesis and Tumour-Selective Toxicity of Novel 1-[3-{3,5-Bis(benzylidene)-4-oxo-1-piperidino}-3-oxopropyl]-4-piperidone Oximes and Related Quaternary Ammonium Salts. Molecules (Basel, Switzerland) 26 (23) (2021)
Mehtap TuĞrak, Halise Inci Gul, Hiroshi Sakagami, Ruya Saglamtas, İlhami Gulçin
Synthesis and biological evaluation of new pyrazolebenzene-sulphonamides as potential anticancer agents and hCA I and II inhibitors. Turkish journal of chemistry 45 (3) (2021)
Kunihiko Fukuchi, Takuro Koshikawa, Daisuke Asai, Megumi Inomata, Hiroshi Sakagami, Hiromu Takemura, Taisei Kanamoto, Hikaru Aimi, Yuji Kikkawa
Lignosulfonate Rapidly Inactivates Human Immunodeficiency and Herpes Simplex Viruses. Medicines (Basel, Switzerland) 8 (10) (2021)
Hiroshi Sakagami, Toshiko Furukawa, Keitaro Satoh, Shigeru Amano, Yosuke Iijima, Takuro Koshikawa, Daisuke Asai, Kunihiko Fukuchi, Hiromu Takemura, Taisei Kanamoto, Satoshi Yokose
Re-Evaluation of Chemotherapeutic Potential of Pyoktanin Blue. Medicines (Basel, Switzerland) 8 (7) (2021)
Praveen K Roayapalley, Hiroshi Sakagami, Keitaro Satoh, Shigeru Amano, Kenjiro Bandow, Renato J Aguilera, Karla G Cano Hernandez, Austre Y Schiaffino Bustamante, Stephen G Dimmock, Rajendra K Sharma, Umashankar Das, Jonathan R Dimmock
Cytotoxic Tumour-Selective 1,5-Diaryl-3-Oxo-1,4-Pentadienes Mounted on a Piperidine Ring. Medicines (Basel, Switzerland) 8 (12) (2021)
Hideaki Abe, Miwa Okazawa, Takahiro Oyama, Hiroaki Yamazaki, Atsushi Yoshimori, Takanori Kamiya, Mitsutoshi Tsukimoto, Koichi Takao, Yoshiaki Sugita, Hiroshi Sakagami, Takehiko Abe, Sei-Ichi Tanuma
A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling. Medicines (Basel, Switzerland) 8 (4) (2021)
Li Xiao, Hiroshi Sakagami, Nobuhiko Miwa
ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? Viruses 12 (5) (2020)
Yoshiaki Sugita, Koichi Takao, Yoshihiro Uesawa, Junko Nagai, Yosuke Iijima, Motohiko Sano, Hiroshi Sakagami
Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity against Human Oral Squamous Cell Carcinoma. Medicines (Basel, Switzerland) 7 (9) (2020)
Kunihiko Fukuchi, Hiroshi Sakagami, Yoshiaki Sugita, Koichi Takao, Daisuke Asai, Shigemi Terakubo, Hiromu Takemura, Hirokazu Ohno, Misaki Horiuchi, Madoka Suguro, Tomohiro Fujisawa, Kazuki Toeda, Hiroshi Oizumi, Toshikazu Yasui, Takaaki Oizumi
Quantification of the Ability of Natural Products to Prevent Herpes Virus Infection. Medicines (Basel, Switzerland) 7 (10) (2020)
Hiroshi Sakagami
Introduction to the Special Issue "Biological Efficacy of Natural and Chemically Modified Products against Oral Inflammatory Lesions". Medicines (Basel, Switzerland) 6 (2) (2019)

Hiroshi Sakagami.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hiroshi Sakagami